EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische Studie

Pulsed-Field vs Thermal Catheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy

Samy Gribissa, Thomas Kueffer, Sven Knecht, Xavier Waintraub, Nicolas Badenco, Philippe Charron, Pauline Pinon, Raphael King, Estelle Gandjbakhch, Guillaume Duthoit, Christian Sticherling, Tobias Reichlin und 1 weitere

JACC: Clinical Electrophysiology · 2025-06 · 11 (6) · 1205-1215

DOI: 10.1016/j.jacep.2025.01.009 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JACC: Clinical Electrophysiology, 2025-06. Verfasst von Samy Gribissa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Département de Cardiologie, Sorbonne Université, AP-HP, Hôpital Universitaire Pitié-Salpêtrière, Paris, France. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiomyopathy, Hypertrophic, Catheter Ablation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulsed-field ablation (PFA) may be beneficial for the treatment of atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM). OBJECTIVES: The goal of this study was to compare the safety and efficacy of PFA and thermal ablation in patients with HCM and AF. METHODS: From 2016 to 2024, patients with HCM undergoing a first AF ablation using PFA or thermal ablation (cryoballoon or radiofrequency) were retrospectively included from 3 French and Swiss centers. Freedom from atrial arrhythmia (AA) recurrence at the 12-month follow-up was assessed. RESULTS: Overall, 109 patients (median age 60 years; 68% male; 43% paroxysmal AF) with HCM underwent PFA (n = 58) or thermal ablation (n = 51) of AF. In addition to pulmonary vein (PV) isolation, extra-PV ablation was performed in 62% of PFA cases and in 18% of thermal cases. PFA was associated with shorter median procedure times than thermal ablation (81 minutes [Q1-Q3: 60-110 minutes] vs 132 minutes [Q1-Q3: 75-190 minutes]; P < 0.0001) and with less postprocedural heart failure (n = 0 vs n = 4; P = 0.03). Freedom from AA recurrence was 57% (95% CI: 46%-67%) after 12 months. PFA was associated with less AA recurrence than thermal ablation (adjusted HR: 0.46; 95% CI: 0.23-0.91; P = 0.03). Extra-PV ablation was associated with more sustained AA recurrence with thermal ablation (HR: 3.07; 95% CI: 1.21-7.82; P = 0.02) but not with PFA (HR: 1.07; 95% CI: 0.35-3.27; P = 0.91). CONCLUSIONS: In patients with HCM and AF, PFA seems to be associated with better safety and efficacy outcomes than thermal ablation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCardiomyopathy, HypertrophicCatheter AblationHumansMaleFemaleMiddle AgedRetrospective StudiesAgedTreatment OutcomeRecurrencePulmonary VeinsAdult

Stichwörter der Autor:innen

atrial arrhythmiacardiomyopathycryoballoon ablationpulmonary vein isolationradiofrequency ablation

Autor:innen und Institutionen

  • Département de Cardiologie, Sorbonne Université, AP-HP, Hôpital Universitaire Pitié-Salpêtrière, Paris, France.
  • Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Cardiology, University Hospital Basel, Basel, Switzerland.
  • Département de Cardiologie, Sorbonne Université, AP-HP, Hôpital Universitaire Pitié-Salpêtrière, Paris, France; Département de Génétique, Centre de Références des Maladies Cardiaques Héréditaires ou rares, Sorbonne Univ…
  • Département de Cardiologie, Sorbonne Université, AP-HP, Hôpital Universitaire Pitié-Salpêtrière, Paris, France. Electronic address: mikael.laredo@aphp.fr.

Zitieren

APA

Gribissa, S., Kueffer, T., Knecht, S., Waintraub, X., Badenco, N., Charron, P., Pinon, P., King, R., Gandjbakhch, E., Duthoit, G., Sticherling, C., Reichlin, T., & Laredo, M. (2025). Pulsed-Field vs Thermal Catheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. JACC: Clinical Electrophysiology, 11(6), 1205-1215. https://doi.org/10.1016/j.jacep.2025.01.009

Vancouver

Gribissa S, Kueffer T, Knecht S, Waintraub X, Badenco N, Charron P, et al. Pulsed-Field vs Thermal Catheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. JACC: Clinical Electrophysiology. 2025;11(6):1205-1215. doi:10.1016/j.jacep.2025.01.009

BibTeX
@article{Gribissa2025,
  author = {Gribissa, Samy and Kueffer, Thomas and Knecht, Sven and Waintraub, Xavier and Badenco, Nicolas and Charron, Philippe and Pinon, Pauline and King, Raphael and Gandjbakhch, Estelle and Duthoit, Guillaume and Sticherling, Christian and Reichlin, Tobias and Laredo, Mikael},
  title = {Pulsed-Field vs Thermal Catheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy},
  journal = {JACC: Clinical Electrophysiology},
  year = {2025},
  volume = {11},
  number = {6},
  pages = {1205--1215},
  doi = {10.1016/j.jacep.2025.01.009}
}
Kostenlos starten →